News Releases

Month Year

Email Alerts

Feb 11, 2008

Study by Leading Economist Identifies Potential for $378 Billion of Savings From Follow On Biologics
Feb 5, 2008

Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
Feb 5, 2008

Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
Jan 28, 2008

Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis
Jan 22, 2008

Insmed Completes External Assessment of Myotonic Muscular Dystrophy Market
Dec 18, 2007

Insmed Receives FDA Orphan Drug Designation for IPLEX(TM) in the Treatment of Myotonic Muscular Dystrophy
Dec 12, 2007

Insmed Awarded $2.1 Million by Muscular Dystrophy Association
Dec 6, 2007

Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
Dec 6, 2007

Insmed Appoints Dennis M. Lanfear to Board Of Directors
Dec 3, 2007

Insmed Retains FD and Gibraltar Associates for Investor Relations and Corporate Communications
Nov 13, 2007

Insmed Advances Follow on Biologics Initiative
Nov 8, 2007

Insmed Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2007
Nov 5, 2007

Insmed Announces Initiation of Phase II Clinical Trial with IPLEX(TM) in Myotonic Muscular Dystrophy
Oct 24, 2007

Insmed Announces Third Quarter Earnings Release Date and Conference Call
Oct 23, 2007

Insmed to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Oct 3, 2007

Insmed to Present at the 2007 BIO Investor Forum on Wednesday, October 10, 2007
Aug 2, 2007

Insmed Reports Financial Results for Second Quarter and First Half of 2007
Jul 25, 2007

Insmed Announces Second Quarter and First Half Earnings Release Date and Conference Call
Jul 9, 2007

Insmed Inc. to Present at C.E. Unterberg, Towbin Growth Conference
Jun 26, 2007

Insmed Inc. Welcomes Studies Linking IGFBP-3 to Prevention of Blindness in Premature Infants
Jun 25, 2007

Experienced Biopharmaceutical Executive Steve Glover Joins Insmed; Will Lead Development of Follow-on Biologics
Jun 19, 2007

Insmed Receives NASDAQ Deficiency Notice Relating to Minimum Bid Price
May 10, 2007

Insmed Incorporated Reports Financial Results for First Quarter Ended March 31, 2007
May 7, 2007

Insmed Announces First Quarter Earnings Release Date and Conference Call
May 4, 2007

Insmed Raises Approximately $18.2 Million in Registered Direct Offering
May 3, 2007

Insmed Announces Promising Results From IPLEX Phase II Myotonic Muscular Dystrophy Clinical Study
May 2, 2007

Insmed CEO Geoffrey Allan Testifies at Energy and Commerce Committee Hearing
Apr 30, 2007

Insmed Releases Positive Results from IPLEX Phase II HIV-Associated Adipose Redistribution Syndrome Clinical Study
Apr 25, 2007

Insmed Inc. Releases Investor Fact Sheet with Updates on Drug Development Progress
Mar 26, 2007

Insmed CEO Geoffrey Allan Testifies at Congressional Hearing
Mar 16, 2007

Insmed Announces Additional Information In Compliance With NASDAQ Rules
Mar 15, 2007

Insmed Inc. Reports Financial Results for Fourth Quarter and Twelve Months
Mar 10, 2007

Update: Insmed to Hold 2006 Q4 and Year End Earnings Results
Mar 9, 2007

Insmed to Hold 2006 Q4 and Year End Earnings Results
Mar 7, 2007

Insmed Announces Restructure, Settlement Ending IPLEX(TM) Patent Dispute
Mar 6, 2007

Insmed to Discuss Litigation Settlement with Tercica
Jan 10, 2007

Italian Ministry of Health Requests IPLEX(TM) for Treatment of ALS (Lou Gehrig's Disease)
Dec 13, 2006

Insmed Announces Positive IPLEX(TM) Product Information At GRS-IGF Society Meeting in Kobe, Japan
Dec 7, 2006

Insmed to Host Litigation Update Conference Call
Dec 6, 2006

Insmed Patent Litigation Verdict Announced
Nov 21, 2006

Insmed to Present at Upcoming Investor Conference in NYC
Nov 3, 2006

Insmed Incorporated Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2006
Oct 31, 2006

Insmed Inc. to Announce 2006 Third Quarter Financial Results
Oct 31, 2006

Jody LoMenzo Named Director, Investor Relations and Corporate Communications
Oct 30, 2006

Insmed to Present at Upcoming Conferences
Oct 25, 2006

Former Amgen Manufacturing Executive Joins Insmed
Oct 24, 2006

Insmed Announces Addition of Top 25 Patent Lawyer to Litigation Team
Oct 17, 2006

Insmed to Present at the BIO Investor Forum Meeting
Oct 16, 2006

Insmed Sues Tercica for False Advertising
Oct 5, 2006

Insmed Provides Update Concerning Virginia Unfair Competition Litigation

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your
email alerts.

View the latest Insmed Investor Presentation

Download

Our Global Company

Current Clinical Trials

Our Research Team

Our Global Company

Current Clinical Trials

Our Research Team

Footer